ebook img

Journal of Internal Medicine 1991: Vol 229 Index PDF

13 Pages·1991·2.5 MB·English
by  
Save to my drive
Quick download
Download
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.

Preview Journal of Internal Medicine 1991: Vol 229 Index

Journal of Internal Medicine 1991; 229: 561-566 Author Index Aase O, see Jonsbu J et al., 143 diabetic patients: a comparison of equimolar amounts of Abela Jr BM, see Falke P et al., 521 porcine and semi-synthetic human insulin, 293 Aberg H, see Asplund R, 131 Benestad AM, see Aursnes I et al., 325 Abildgaard U, see Andersen }5 et al., 253 Bengtsson C, see Petersen K et al., 407 Abramowicz M, see Somville JF et al., 89 Berg A-L, Hansson P & Nilsson-Ehle P. ACTH 1-24 decreases Agbedana EO, see Ahaneku JE et al., 17 hepatic lipase activities and low density lipoprotein Agewall S, Rhea B, Persson B, Karlberg B, Wallin G & concentrations in healthy men, 201 Andersson OK. Reflexogenic neuronal and humoral responses Berg KJ, see Holdaas Re t al., 163 to selective stimulation of low-pressure cardiopulmonary Berger M, see Sawicki PT et al., 489 receptors in man, 151 Berglund B & Ekblom B. Effect of recombinant human Ahaneku JE, Olubuyide JO, Agbedana EO & Taylor GO. erythropoietin treatment on blood pressure and some Changes in plasma high density lipoprotein cholesterol and haematological parameters in healthy men, 125 phospholipid in acute viral hepatitis and cholestatic jaundice, Berglund B, see Reichard Pe t al., 9 17 Berglund J, Christensen SB, Dymling JF & Hallgren B. The Al-Mashhadani SA, see Santhosh-Kumar CR et al., 493 incidence of recurrence and hypothyroidism following Aldershvile J, see Andersen JS et al., 253 treatment with antithyroid drugs, surgery or radioiodine in Algotsson A, Sanz E & Alvan G. Steady-state concentrations all patients with thyrotoxicosis in Malm6 during the period and dosage of digoxin in relation to kidney function in 1970-1974, 435 hospitalized patients over 70 years of age, 247 Bergstrém B, see Sundkvist G et al., 505 Alvan G, see Algotsson A et al., 247 Bernard E, see Dellamonica P et al., 103 Andersen JS, Egeblad H, Abildgaard U, Aldershvile J & Beswick AD, Fehily AM, Sharp DS, Renaud S & Giddings J. Godtfredsen J. Atrial fibrillation and left atrial enlargement: Long-term diet modification and platelet activity, 511 cause or effect? 253 Bianchi Porro G, Caruso I, Petrillo M, Montrone F & Ardizzone Andersen V, see Remvig L et al., 73 S. A double-blind gastroscopic evaluation of the effects of Andersson OK, see Agewall S et al., 151 etodolac and naproxen on the gastrointestinal mucosa of Andersson OK, see Widgren BR et al., 217 rheumatic patients, 5 Angelin B, see Carrella M et al., 241 Bierman EL, see Duell PB, 97 Antonini R, see Fazio S et al., 41 Binder C, see Bendtson I, 293 Araki W, Hirose S, Mimori Y, Nakamura S, Kimura J, Ohno K Binder C, see Snorgaard O et al., 343 & Shimada T. Familial hypobetalipoproteinaemia complicated Binner L, see Koenig W et al., 533 by cerebellar ataxia and steatocystoma multiplex, 197 Bisgaard C, see Sloth H et al., 443 Ardizzone S, see Bianchi Porro G et al., 5 Bjorck S, see Nassberger L et ai., 261 Ariad S, Dvilansky A, Sobel R & Nathan I. Plasma von Blychert E, see Kjellstr6m T et al., 233 Willebrand factor levels and congestive heart failure, 557 Bolinder J, see Sundkvist G et al., 61 Arnalich F, see Camacho J et al., 49 Boman K, see Jansson J-H et al., 309 Arnesen KE, see Jonsbu J et al., 143 Boman K, see Olofsson B-O et al., 55 Artur Y, see Guemouri L et al., 297 Bongiovi S, see Casiglia E et al., 501 Aspholm R, see Seppala T et al., 23 Boni M, see Casiglia E et al., 501 Asplund R & Aberg H. Diurnal variation in the levels of Boyd IW. Allopurinol-azathioprine interaction antidiuretic hormone in the elderly, 131 Brandi L, see Thaysen JH et al., 363 Aursnes I, Benestad AM, Sivertssen E, Skjaggestad 0 & Brandtzaeg P, see Stavem P et al., 193 Gronseth K. Degree of coronary artery disease predicted by Britz A, see Reichard P et al., 9 exercise testing, 325 Brosen K, see Jensen J et al., 29 Azemoto R, see Ogawa M et al., 189 Brosstad F, see Stavem P et al., 193 Buhl M, see Ernst E et al., 457 Baehrendtz S, see Ludwigs UG et al., 117 Bakker PJM, see de Wit R et al., 35, 463, 539 Caidahl K & Kazzam E. Left ventricular hypertrophy and Ballegaard S, Meyer CN & Trojaborg W. Acupuncture in duration of systemic sclerosis, 384 angina pectoris: does acupuncture have a specific effect? 357 Camacho J, Arnalich F, Zamorano AF & Vazquez JJ. Serum Baralle FE, see Fazio S et al., 41 erythropoietin levels in the anaemia of chronic disorders, 49 Bassan H, see Odeh Me t al., 289 Cardoso M de FL, see Kraemer ES et al., 382 Baynes C, Henderson AD, Hughes CL, Richmond W, Johnston Carles M, see Dellamonica Pe t al., 103 DG & Elkeles RS. Determinants of mild fasting Carrella M, Ericsson S, Del Piano C, Angelin B & Einarsson K. hypertriglyceridaemia in non-insulin-dependent diabetes, 267 Effect of cholestyramine treatment on biliary lipid secretion Beermann B, see Sylvén C et al., 171 rates in normolipidaemic men, 241 Bendtson I & Binder C. Counterregulatory hormonal response Caruso I, see Bianchi Porro G et al., 5 to insulin-induced hypoglycaemia in insulin-dependent Casiglia E, Bongiovi S, Paleari CD, Petucco S, Boni M, Colangeli 561 562 AUTHOR INDEX G, Penzo M & Pessina AC. Haemodynamic effects of coffee Falke P, Abela Jr BM, Krakau CET, Lilja B, Lindgarde F, Maly and caffeine in normal volunteers: a placebo-controlled P & Stavenow L. High frequency of asymptomatic visual field clinical study, 501 defects in subjects with transient ischaemic attacks or minor Cederholm T, see Sylvén C et al., 171 strokes, 521 Celsing F, see Hast R et al., 381 Fauchald P, see Holdaas Re t al., 163 Christensen SB, see Berglund J et al., 435 Fazio S, Sidoli A, Vivenzio A, Maietta A, Giampaoli S, Menotti Colangeli G, see Casiglia E et al., 501 A, Antonini R, Urbinati G, Baralle FE & Ricci G. A form of Conn HO. Breakthroughs in ascites: effects on bottom lines, 1 familial hypobetalipoproteinaemia not due to a mutation in Czirjak L, see Hegediis I, 383 the apolipoprotein B gene, 41 Fehily AM, see Beswick AD et al., 511 Dahlqvist SR, see Nilsson TK et al., 558 Fernandez A, see Povoa Pe t al., 475 Danielsson M, see Isaksson H et al., 421 Forde OH, see Nilssen OH, 497 Danner SA, see De Wit R et al., 35 Forsberg K, see Olofsson B-O et al., 55 De Backer G, see Renaud Se t al., 79 Fredholm BB. Diversity in receptor signalling, cellular de Leeuw PW, see Veen C et al., 549 individuality and the search for selective drugs, 391 De Wit R, Danner SA, Bakker PJM, Lange JMA, Eeftinck Frenzel H, see Sawicki PT et al., 489 Schattenkerk JKM & Veenhof CBN. Combined zidovudine and Friedman PJ. Serum creatinine: an independent predictor of interferon-alpha treatment in patients with AIDS-associated survival after stroke, 175 Kaposi's sarcoma, 35 Fugleholm AM, see Launbjerg J et al., 351 De Wit R, Hoek FJ, Bakker PJM & Veenhof CHN. The value of Fujita J. Negayama K, Higuchi K, Nakano M, Yamaji Y & Irino MCA, CA 15-3, CEA and CA-125 for discrimination S. Changes in clinically separated strains of glucose non- between metastatic breast cancer and adenocarcinoma of fermented Gram-negative bacilli following the induction of other primary sites, 463 imipenem/cilastatin, 559 De Wit R, Raasveld MHM, ten Berge RJM, van der Wouw PA, Bakker PJM & Veenhof CHN. Interleukin-6 concentrations in Galloe AM, Graudal N, Petersen JR, Leth P & Galloe M. The the serum of patients with AIDS-associated Kaposi's sarcoma effect of the calcium antagonist, isradipine, on working during treatment with interferon-alpha, 539 capacity, pulmonary function, morbidity and survival rate in Del Piano C, see Carrella M et al., 241 patients with severe chronic obstructive pulmonary disease Dellamonica P, Bernard E, Pradier C, Durant J, Etesse-Carsenti (COPD): a randomized, double-blind, placebo-controlled H, Elbaze P, Mondain V & Carles M. AZT - does it prevent study, 447 occurrence of salmonelloses in AIDS patients? 103 Galloe M, see Galloe AM et al., 447 Djoseland O, see Holdaas Re t al., 163 Ganguly PK. Antioxidant therapy in congestive heart failure, 205 Ducla-Soares J, see Povoa Pe t al., 475 Gerglund G, see Widgren BR et al., 217 Duell PB & Bierman EL. Potential role of insulin in the Giampaoli S, see Fazio § et al., 41 clearance of remnant lipoproteins in dysbetalipoproteinaemia, Giddings J, see Beswick AD et al., 511 97 Gill EP, see Hayes TG et al., 467 Durant J, see Dellamonica P et al., 103 Gjorup T, see Jarlov AE et al., 159 Dvilansky A, see Ariad Se t al., 557 Godtfredsen J, see Andersen JS et al., 253 Dymling JF, see Berglund J et al., 435 Gonzalez Porque P, see Ruiz-Palomo Fe t al., 93 Grabensee B, see Plum J, 209 Edhag O, see Rasmanis G et al., 135 Grabner P, see Stavem Pe t al., 193 Eeftinck Schattenkerk JKM, see De Wit Re t al., 35 Gram LF, see Jensen J et al., 29 Egeblad H, see Andersen JS et al., 253 Grankvist K, see Olofsson B-O et al., 55 Egeblad H, see Launbjerg J et al., 351 Graudal N, see Galloe AM et al., 447 Egusa G, see Tanaka S et al., 371 Gréen K, see Rasmanis G et al., 135 Einarsson K, see Carrella M et al., 241 Gro&mann G, see Schmidt A et al., 527 Ekblom B, see Berglund B, 125 Groeneveld ABJ, see Oudkerk Pool M et al., 377 Ekfors T, see Leino R et al., 553 Grondal S, Eriksson B, Hamberger B & Theodorsson E. Plasma Ekman M, see Hast R et al., 381 chromogranin A+B, neuropeptide Y and catecholamines in Elbaze P, see Dellamonica P et al., 103 pheochromocytoma patients, 453 Elkeles RS, see Baynes C et al., 267 Gronseth K, see Aursnes I et al., 325 Engan T, see Hannisdal E, 337 Grove A, see Sloth H et al., 443 Ericsson S, see Carrella M et al., 241 Guemouri L, Herbeth B, Artur Y, Jeandel C. & Siest G. Weak Ericsson U-B & Lindgiarde F. Effects of cigarette smoking on relationships between blood antioxidant enzymes and serum thyroid function and the prevalence of goitre, thyrotoxicosis lipids or apolipoproteins, 297 and autoimmune thyroiditis, 67 Eriksen EF, see Kassem M et al., 275 Haarbo J, see Kristensen KS et al., 257 Erikssen J, see Jonsbu J et al., 143 Hallas J, see Jensen J et al., 29 Eriksson B, see Grondal S et al., 453 Hallgren B, see Berglund J et al., 435 Ernst E, see Koenig W et al., 533 Hamberg O, see Pedersen FM et al., 517 Ernst E, Resch KL, Matrai A, Buhl M, Schlosser P & Paulsen Hamberger B, see Gréndal S et al., 453 HF. Impaired blood rheology: a risk factor after stroke? 457 Hannisdal E & Engan T. Blood analyses and survival in Etesse-Carsenti H, see Dellamonica P et al., 103 symptom- and survey-detected lung cancer patients, 337 AUTHOR INDEX 563 Hansen JM, see Jarlov AE et al., 159 Erikssen J & Koss A. Rapid and correct diagnosis of Hansen NE, see Remvig L et al., 73 myocardial infarction: standardized case history and clinical Hansson P, see Berg A-L et al., 201 examination provide important information for correct Hara H, see Tanaka Se t al., 371 referral to monitored beds, 143 Hartmann A, see Holdaas R et al., 163 Jonsson O, see Widgren BR et al., 2 4 Hast R, Celsing F, Ekman M & Stenke L. Response to Joossens JV, see Renaud Se t al., 79 recombinant human erythropoietin treatment in myelodysplastic syndromes (MDS), 381 Kaiser S, see Sawicki PT et al., 489 Hauner H, see Schmidt A et al., 527 Karlberg B, see Agewall S et al., 151 Hayes TG, Gill EP & Swarna U. Osteomyelitis of the wrist in a Karlberg J & Mossberg H-O. Weight-for-height standards in patient with Hodgkin’s disease, 467 adulthood, 303 Hegeditis I & Czirjak L. Septum and posterior wall thickness Karle H, see Remvig L et al., 73 and disease duration in systemic sclerosis, 383 Kassem M, Eriksen EF, Melsen F & Mosekilde L. Antacid- Hegediis L, see Jarlov AE et al., 159 induced osteomalacia: a case report with a Hehr R, see Koenig W et al., 533 histomorphometric analysis, 275 Heinemann L, see Sawicki PT et al., 489 Kaukianen A, see Seppala T et al., 23 Henderson AD, see Baynes C et al., 267 Kazzam E, see Caidahl K, 384 Henriksson P, see Rasmanis G et al., 135 Kimura J, see Araki W et al., 197 Herbeth B, see Guemouri L et al., 297 King JC, see Rosen SD et al., 297 Herlitz H, see Widgren BR et al., 217 Kjellstr6m T, Blychert E & Lindgiirde F. Felodipine in the Hernandez-Madrid A, Moro C, Marin Huerta E & Rayo J. treatment of hypertensive type II diabetics: effect on glucose Third-degree atrioventricular block in an athlete, 375 homeostasis, 233 Hess K, see Pedersen FM et al., 517 Kobayashi I, see Mori M et al., 285 Higgy KE, see Santhosh-Kumar CR et al., 493 Kobayashi S, see Mori M et al., 285 Higuchi K, see Fujita J et al., 559 Koenig W, see Schmidt A et al., 527 Hildebrand IL, see Sylvén C et al., 171 Koenig W, Sund M, Ernst E, Hehr R, Binner L, Rosenthal J & Hirose S, see Araki W et al., 197 Hombach V. Effects of felodipine ER and hydrochlorothiazide Hoek FJ, see De Wit R et al., 463 on blood rheology in essential hypertension — a randomized, Holdaas R, Hartmann A, Lien MG, Nilsen L, Jervell J, Fauchald double-blind, cross-over study, 533 P, Djoseland O & Berg KJ. Contrasting effects of lisinopril and Konarski-Svensson JC, see Isaksson H et al., 421 nifedipine on albuminuria and tubular transport functions in Kornitzer M, see Renaud Se t al., 79 insulin-dependent diabetics with nephropathy, 163 Korpela H, see Luoma PV, 280 Hollak CEM, Prummel MF & Tiel-van Buul MMC. Bilateral Koskinen P, see Sundkvist G et al., 61 adrenal tumours in primary aldosteronism: localization of a Koss A, see Jonsbu J et al., 143 unilateral aldosteronoma by dexamethasone suppression Kraemer ES, Cardoso M de FL & Yamamura Y. Acupuncture in scan, 545 angina pectoris, 382 Hombach V, see Koenig W et al., 533 Krakau CET, see Falke P et al., 521 Hombach V, see Schmidt A et al., 527 Kristensen KS, Haarbo J, Munkvad S & Stoltenberg M. Early Hughes CL, see Baynes C et al., 267 thrombolytic treatment reduces analgesic requirement in patients with myocardial infarction, 257 Irino S, see Fujita J et al., 559 Kupari M. Diastolic heart function and failure, 479 Iruchijima T, see Mori M et al., 285 Isaksson H, Danielsson M, Rosenhamer G, Konarski-Svensson Ladefoged K, see Launbjerg J et al., 351 JC & Ostergren J. Characteristics of patients resistant to Lafvas I, see Olofsson B-O et al., 55 antihypertensive drug therapy, 421 Landin K, Tengborn L & Smith U. Treating insulin resistance in hypertension with metformin reduces both biood pressure Jansen T, see Schmidt A et al., 527 and metabolic risk factors, 181 Janssen MJ, see Oudkerk Pool M et al., 377 Lange JMA, see De Wit R et al., 35 Jansson E, see Sylvén C et al., 171 Lapidus L, see Petersen K et al., 407 Jansson J-H, Johansson B, Boman K & Nilsson TK. Lassen LH, see Snorgaard O et al., 343 Hypofibrinolysis in patients with hypertension and elevated Launbjerg J, Egeblad H, Nielsen NH, Fugleholm AM & cholesterol, 309 Ladefoged K. Bleeding complications to oral anticoagulant Jarlov AE, Hegediis L, Gjorup T & Hansen JM. Observer therapy: multivariate analysis of 1010 treatment years in variation in the clinical assessment of the thyroid gland, 159 551 outpatients, 351 Jeandel C, see Guemouri Le t al., 297 Laurberg P, Pedersen KM, Vestergaard H & Sigurdsson G. High Jensen J, Nielsen LH, Lyhne N, Hallas J, Brosen K & Gram LF. incidence of multinodular toxic goitre in the elderly Drugs and femoral neck fracture: a case-control study, 29 population in a low iodine intake area vs. high incidence of Jervell J, see Holdaas R et al., 163 Graves’ disease in the young in a high iodine intake area: Jespersen J, see Marckmann P et al., 317 comparative surveys of thyrotoxicosis epidemiology in East- Johansson A-C, see Nassberger Le t al., 261 Jutland Denmark and Iceland, 415 Johansson B, see Jansson J-H et al., 309 Leino R, Liippo K & Ekfors T. Sulphasalazine-induced Johnston DG, see Baynes C et al., 267 reversible hypersensitivity pneumonitis and fatal fibrosing Jonsbu J, Rollag A, Aase O, Lippestad CT, Arnesen KE, alveolitis: report of two cases, 553 564 AUTHOR INDEX Lenaers AP, see Somville JF et al., 89 Negayama K, see Fujita J et al., 559 Leonhardt T, see Olsson R, 471 Neve PE, see Somville JF et al., 89 Leth P. see Galloe AM et al., 447 Nielsen LH, see Jensen J et al., 29 Leth T, see Marckmann Pe t al., 317 Nielsen NH, see Launbjerg J et al., 351 Levander S, see Reichard P et al., 9 Nielsen OJ, see Thaysen JH et al., 363 Lewis B. On lowering lipids in the post-infarction patient, 483 Nilsen L, see Holdaas R et al., 163 Lien MG, see Holdaas Re t al., 163 Nilssen OH & Forde OH. The Tromso Study: the positive Liippo K, see Leino R et al., 553 predictive value of gamma-glutamyltransferase and an Lilja B, see Falke P et al., 521 alcohol questionnaire in the detection of early-stage risk Lilja B, see Sundkvist G et al., 505 drinkers, 497 Lind P, see Sundkvist G et al., 505 Nilsson TK, see Jansson J-H et al., 309 Lindahl G, see Sundkvist G et al., 61 Nilsson TK, Norberg B, Wallberg-Jonsson S & Dahlqvist SR. Lindblad R & Rédjer S. A case of severe pancytopenia caused Von Willebrand factor in plasma as risk indicator for by ibuprofen, 281 cardiovascular events, 558 Lindgarde F, see Ericsson U-B, 67 Nilsson-Ehle P, see Berg A-L et al., 201 Lindgarde F, see Falke P et al., 521 Nixon PGF, see Rosen SD et al., 297 Lindgarde F, see Kjellstrém T et al., 233 Norberg B, see Mérnstad H, 387 Lindstedt G, see Petersen K et al., 407 Norberg B, see Nilsson TK et al., 558 Lippestad CT, see Jonsbu J et al., 143 Nordhagen R, see Stavem P et al., 193 Lithner F, see Olofsson B-O et al., 55 Nystr6m B, see Petersen K et al., 407 Ludwigs UG, Baehrendtz S, Wanecek M & Matell G. Mechanical ventilation in medical and neurological diseases: Odeh M, Oliven A, Rauchfleisch S & Bassan H. Dilated 11 years of experience, 117 cardiomyopathy associated with Chlamydia trachomatis Lundberg P-A, see Petersen K et al., 407 infection, 289 Luoma PV & Korpela H. Responses to the observations of Ogawa M, Azemoto R, Makino Y, Mori Y, Ueda S, Wakashin M Guemouri et al., 280 & Ohto M. Pneumothorax in a patient with Wegener's Lyhne N, see Jensen J et al., 29 granulomatosis during treatment with immunosuppressive agents, 189 Maietta A, see Fazio S et al., 41 Ohno K, see Araki W et al., 197 Makino Y, see Ogawa M et al., 189 Ohshima K, see Mori M et al., 285 Maly P, see Falke P et al., 521 Ohto M, see Ogawa M et al., 189 Marckmann P, Jespersen J, Leth T & Sandstrém B. Effect of fish Okazaki M, see Tanaka Se t al., 371 diet versus meat diet on blood lipids, coagulation and Oliven A, see Odeh M et al., 289 fibrinolysis in healthy young men, 317 Olofsson B-O, Grankvist K, Olsson T, Boman K, Forsberg K, Marin Huerta E, see Hernandez-Madrid A et al., 375 Lafvas I & Lithner F. Assessment of hypothalamic-pituitary Matell G, see Ludwigs UG et al., 117 function in patients with familial amyloidotic Matrai A, see Ernst E et al., 457 polyneuropathy, 55 Melsen F, see Kassem M et al., 2 / 5 Olsson R & Leonhardt T. Cholestatic liver reaction during Menotti A, see Fazio S et al., 41 heparin therapy, 471 Meyer CN, see Ballegaard S et al., 357 Olsson T, see Olofsson B-O et al., 55 Mimori Y, see Araki W et al., 197 Olubuyide JO, see Ahaneku JE et al., 17 Mochizuki H, see Tanaka Se t al., 371 Ostergren J, see Isaksson H et al., 421 Mondain V, see Dellamonica P et al., 103 Oudkerk Pool M, Janssen MJ, van der Valk P & Groeneveld Montrone F, see Bianchi Porro G et al., 5 ABJ. Adrenocortical insufficiency: a rare presentation of Mori M, Shoda Y, Yamada M, Murakami M, Iruchijima T, Non-Hodgkin's lymphoma, 377 Ohshima K, Kobayashi I & Kobayashi S. Central Ovesen L, see Pedersen FM et al., 517 hypothyroidism due to isolated TRH deficiency in a depressive man, 285 Padfield PL, see Teelucksingh § et al., 543 Mori Y, see Ogawa M et al., 189 Paleari CD, see Casiglia E et al., 501 Mornstad H & Norberg B. Cavity of ignorance, 387 Palma-Carlos AG, see Povoa P et al., 475 Moro C, see Hernandez-Madrid A et al., 375 Partinen M, see Seppala T et al., 23 Mosekilde L, see Kassem M et al., 27 5 Paulsen HF, see Ernst E et al., 457 Mossberg H-O, see Karlberg J, 303 Pedersen FM, Hamberg O, Hess K & Ovesen L. The effect of Munkvad §, see Kristensen KS et al., 257 dietary vitamin K on warfarin-induced anticoagulation, 517 Murakami M, see Mori M et al., 285 Pedersen KM, see Laurberg P et al., 415 Pendek R, see Teelucksingh S et al., 543 Nakamura S, see Araki W et al., 197 Penttila A, see Seppala T et al., 23 Naskano M, see Fujita J et al., 559 Penzo M, see Casiglia E et al., 501 Nassberger L, Johansson A-C, Bjérck S & Sj6holm AG. Persson B, see Agewall S et al., 151 Antibodies to neutrophil granulocyte myeloperoxidase and Pessina AC, see Casiglia E et al., 501 elastase: autoimmune responses in glomerulonephritis due to Petersen JR, see Galloe AM et al., 447 hydralazine treatment, 261 Petersen K, Lindstedt G, Lundberg P-A, Bengtsson C, Lapidus L Nathan I, see Ariad S et al., 557 & Nystrém B. Thyroid disease in middle-aged and elderly AUTHOR INDEX 565 Swedish women: thyroid-related hormones, thyroid Prevalence of renal artery stenosis in diabetes mellitus — an dysfunction and goitre in relation to age and smoking, 407 autopsy study, 489 Petrillo M, see Bianchi Porro G et al., 5 Schlosser P, see Ernst E et al., 457 Petucco S, see Casiglia E et al., 501 Schmidt A, GrofS{mann G, Hauner H, Koenig W, Jansen T, Plum J & Grabensee B. Atrial natriuretic peptide in dialysis Stauch M & Hombach V. Left ventricular function and wall patients under various conditions of volume homeostasis, thickness in long-term insulin-dependent diabetes mellitus: 209 an echocardiographic study, 527 Povoa P, Ducla-Soares J, Fernandez A & Palma-Carlos AG. A Seglen PO. Citation frequency and journal impact: valid case of systemic mastocytosis: therapeutic efficacy of indicators of scientific quality? 109 ketotifen, 475 Seppala T, Partinen M, Penttilé A, Aspholm R, Tiainen E & Pradier C, see Dellamonica Pe t al., 103 Kaukianen A. Sudden death and sleeping history among Prummel MP, see Hollak CEM et al., 545 Finnish men, 23 Serrano Rios M, see Ruiz-Palomo F et al., 93 Raasveld MHM, see de Wit Re t al., 539 Sharp DS, see Beswick AD et ai., 511 Rabinowe SL, see Sundkvist G et al., 505 Sherry S. Fifty years of progress with antithrombotic drugs — Rasmanis G, Vesterqvist O, Gréen K, Edhag O & Henriksson P. with much more to come: a perspective, 113 Prostacyclin production in myocardial infarction in the acute Shimada T, see Araki W et al., 197 phase and during follow-up, 135 Shoda Y, see Mori M et al., 285 Rauchfleisch S, see Odeh M et al., 289 Sidoli A, see Fazio S et al., 41 Rayo J, see Hernandez-Madrid A et al., 375 Siest G, see Guemouri i. et al., 297 Reichard P, Berglund B, Britz A, Levander S & Rosengqvist U. Sigurdsson G, see Laurberg P et al., 415 Hypoglycaemic episodes during intensified insulin treatment: Silfvast T. Cause of death in unsuccessful prehospital increased frequency but no effect on cognitive function, 9 resuscitation, 331 Remvig L, Andersen V, Hansen NE & Karle H. Prophylactic Sivertssen E, see Aursnes I et al., 325 effect of self-administered pump-driven subcutaneous IgG Sjdholm AG, see Nassberger L et al., 261 infusion in patients with antibody deficiency: a triple-blind Skjzeggestad @, see Aursnes I et al., 325 cross-over study comparing P-IgG levels of 3 g 1"! versus Sloth H, Bisgaard C & Grove A. Collagenous colitis: a egic*, 73 prospective trial of prednisolone in six patients, 443 Renaud S, see Beswick AD et al., 511 Smith U, see Landin K et al., 181 Renaud S, De Backer G, Thevenon C, Joossens JV, Vermylen J, Snorgaard O, Lassen LH, Rosenfalck AM & Binder C. Glycaemic Kornitzer M & Verstraete M. Platelet fatty acids and function thresholds for hypoglycaemic symptoms, impairment of in two distinct regions of Belgium: relationship to age and cognitive function, and release of counterregulatory dietary habits, 79 hormones in subjects with functional hypoglycaemia, 343 Resch KL, see Ernst E et al., 457 Sobel R, see Ariad S et al., 557 Revilla Y, see Ruiz-Palomo F et al., 93 Somville JF, Lenaers AP, Abramowicz M & Neve PE. High Rhea B, see Agewall S et al., 151 cardiac output as a paraneoplastic syndrome, 89 Ricci G, see Fazio S et al., 41 Stauch M, see Schmidt A et al., 527 Richmond W, see Baynes C et al., 267 Stavem P, Rorvik T, Brandtzaeg P, Brosstad F, Nordhagen R & Rédjer S, see Lindblad R, 281 Grabner P. Gastric lymphoma causing granulocytopenia and Rollag A, see Jonsbu J et al., 143 cold intolerance, with recovery after treatment, 193 Rorvik T, see Stavem P et al., 193 Stavenow L, see Falke P et al., 521 Rosen SD, King JC & Nixon PGF. Insensitivity of the forced Stenke L, see Hast R et al., 381 hyperventilation provocation test, 297 Stoltenberg M, see Kristensen KS et al., 257 Rosenfalck AM, see Snorgaard O et al., 343 Sund M, see Koenig W et al., 533 Rosenhamer G, see Isaksson H et al., 421 Sundkvist G, Lind P, Bergstrém B, Lilja B & Rabinowe SL. Rosenqvist U, see Reichard P et al., 9 Autonomic nerve antibodies and autonomic nerve function Rosenthal J, see Koenig W et al., 533 in Type 1 and Type 2 diabetic patients, 505 Rossner S. Television viewing, life style and obesity, 301 Sundkvist G, Lindahl G, Koskinen P & Bolinder J. Pancreatic Ruiz-Palomo F, Revilla Y, Gonzalez Porque P & Serrano Rios autoantibodies and pancreatic function in Sjégren’s M. Two IgM paraproteins bearing cryoglobulin and anti- syndrome, 61 smooth muscle activities in a patient with Waldenstrém’s Swarna U, see Hayes TG et al., 467 macroglobulinaemia, 93 Sylvén C, Jansson E, Cederholm T, Hildebrand IL & Beermann B. Skeletal muscle depressed calcium and Salonen JT, see Salonen R, 225 phosphofructokinase in chronic heart failure are upregulated Salonen R & Salonen JT. Determinants of carotid intima-media by captopril—a double-blind, placebo-controlled study, thickness: a population-based ultrasonography study in 171 Eastern Finnish men, 225 Szpirt W, see Thaysen JH et al., 363 Sandstrém B, see Marckmann P et al., 317 Santhosh-Kumar CR, Yohannan MD, Higgy KE & Takai S, see Tanaka S et al., 371 Al-Mashhadani SA. Thrombocytosis in adults: analysis of Tanaka S, Okazaki M, Egusa G, Takai S, Mochizuki H, Yamane 777 patients, 493 K, Hara H & Yamakido M. A case of pheochromocytoma Sanz E, see Algotsson A et al., 247 associated with meningioma, 371 Sawicki PT, Kaiser S, Heinemann L, Frenzel H & Berger M. Taylor GO, see Ahaneku JE et al., 17 566 AUTHOR INDEX Teelucksingh S, Pendek R & Padfield PL. Apathetic Veenhof CHN, see De Wit R et al., 539 thyrotoxicosis in adolescence, 543 ven den Hamer CJA, see Veen C et al., 549 ten Berge RJM, see de Wit R et al., 539 Vermylen J, see Renaud S et al., 79 Tengborn L, see Landin K et al., 181 Verstraete M, see Renaud §e t al., 79 Thaysen JH, Nielsen OJ, Brandi L & Szpirt W. Erythropoietin Vestergaard H, see Laurberg Pe t al., 415 deficiency in acute crescentic glomerulonephritis and in total Vesterqvist O, see Rasmanis G et al., 135 bilateral renal cortical necrosis, 363 Vivenzio A, see Fazio S et al., 41 Theodorsson E, see Gréndal S et al., 453 Thevenon C, see Renaud § et al., 79 Wakashin M, see Ogawa M et al., 189 Tiainen E, see Seppala T et al., 23 Wallberg-Jonsson S, see Nilsson TK et al., 558 Tiel-van Buul MMC, see Hollak CEM et al., 545 Wallin G, see Agewall S et al., 151 Tikkanen MJ, see Tilly-Kiesi M, 427 Wanecek M, see Ludwigs UG et al., 117 Tilly-Kiesi M & Tikkanen MJ. Low density lipoprotein density Widgren BR, Herlitz H, Jonsson O, Gerglund G, Wikstrand J & and composition in hypercholesterolaemic men treated with Andersson OK. Normotensive young men with family HMG CoA reductase inhibitors and gemfibrozil, 427 histories of hypertension gain weight and decrease their Trojaborg W, see Ballegaard Se t al., 357 intraerythrocyte sodium content during a 5-year follow-up, 217 Ueda S, see Ogawa M et al., 189 Wikstrand J, see Widgren BR et al., 217 Urbinati G, see Fazio S et al., 41 Yamada M, see Mori M et al., 285 van der Valk P, see Oudkerk Pool M et al., 377 Yamaji Y, see Fujita J et al., 559 van der Wouw PA, see de Wit R et al., 539 Yamakido M, see Tanaka S et al., 371 Vazquez JJ, see Camacho J et al., 49 Yamamura Y, see Kraemer ES et al., 382 Veen C, ven den Hamer CJA & de Leeuw PW. Zinc sulphate Yamane K, see Tanaka Se t al., 371 therapy for Wilson's disease after acute deterioration during Yohannan MD, see Santhosh-Kumar CR et al., 493 treatment with low-dose D-penicillamine, 549 Veenhof CBN, see De Wit R et al., 35 Zamorano AF, see Camacho J et al., 49 Journal of Internal Medicine 1991; 229: 567-571 Subject Index ACE inhibitor Atherosclerosis effect on albuminuria and tubular transport functions, 163 and lipid levels, 483 ACTH 1-24 Atrial dilation effect on hepatic lipase activity, 201 atrial fibrillation and, 253 Acupuncture Atrial fibrillation in angina pectoris, 357 and atrial dilation, 253 Adenocarcinoma Atrial natriuretic peptide and metastatic breast cancer, 463 response to low-pressure receptor activity, 151 Adrenaline peptide in dialysis patients, 209 and plasma chromogranin A+B, 453 Atrioventricular block Adrenocortical insufficiency during exercise, 375 and Non-Hodgkin's lymphoma, 377 Autoimmune thyroiditis Age effects of cigarette smoking on, 67 and platelet functions, 79 Autoimmunity Agranulocytosis pancreatic function in Sjégren’s syndrome, 61 and long-term ibuprofen use, 281 in glomerulonephritis due to hydralazine treatment, 261 AIDS Autonomic nerve antibodies -associated Kaposi's sarcoma, 35, 539 and autonomic nerve function, 505 prevention of salmonelloses in, 103 Autonomic neuropathy Albuminuria and diabetes mellitus, 505 effects of lisinopril and nifedipine on, 163 AZT Alcohol abuse and salmonelloses in AIDS patients, 103 predictive value of gamma-glutamyl! transferase, 497 Aluminium Bilateral adrenal tumours and induction of severe osteomalacia, 275 in primary aldosteronism, 545 Anaemia Bile acids serum erythropoietin levels in, 49 effect of cholestyramine on output rates, 241 and erythropoietin deficiency in renal failure, 363 Bleeding complications Analgesics to oral anticoagulant therapy, 351 requirement in myocardial infarction, 257 Blood lipids Angina pectoris effect of fish diet vs. meat diet, 317 acupuncture, in 357 Blood pressure Antacids effect of recombinant erythropoietin treatment, 125 induction of osteomalacia, 275 effect of metformin treatment, 181 Anti-smooth muscle activities Blood screening in Waldenstrém’s macroglobulinaemia, and survival in lung cancer patients, 337 Antibody activity Body weight in Waldenstr6m’s macroglobulinaemia, 93 hypertension and sodium levels, 217 Anticoagulation Brain function bleeding complications to oral therapy, 351 glycaemic thresholds for impairment of, 343 effect of dietary vitamin K, 517 Breast cancer Antidiuretic hormone and adenocarcinoma, 463 diurnal variation in levels of, 131 Antioxidant therapy Caffeine in congestive heart failure, 205 haemodynamic effects of, 501 Antithrombotic drugs Calcium progress review, 113 levels in chronic heart failure, 171 Apathy Calcium antagonists apathetic thyrotoxicosis, 543 effects on albuminuria and tubular transport functions, 163 Apolipoprotein B treatment of diabetics with felodipine, 233 gene alleles and the hypocholesterolaemic phenotype, 41 in severe chronic obstructive pulmonary disease, 447 levels in cerebellar ataxia and steatocystoma complex, Captopril 197 upregulation of calcium and phosphofructokinase, 171 Arginine vasopressin Cardiac output levels in familial amyloidotic polyneuropathy, 55 as a paraneoplastic syndrome, 89 Ascites Carotid arteries effects on bottom lines, 1 intima-media thickness of, 225 568 SUBJECT INDEX Catecholamines counterregulatory hormonal response to hypoglycaemia in pheochromocytoma patients, 453 in, 293 Cause of death renal artery stenosis in, 489 in unsuccessful prehospital resuscitation, 331 and autonomic nerve antibodies and function, 505 Cerebellar ataxia and left ventricular function, 527 familial hypobetalipoproteinaemia complicated by Diagnosis Cerebral infarction of myocardial infarction, 143 and visual field defects, Diarrhoea Cerebral ischaemia and prednisolone treatment, 443 and visual field defects, Diastolic heart function Cerebrovascular disorders and failure, 479 serum creatinine as a predictor of survival, 175 Dietary fat Chlamydia trachomatis and platelet function, 79 and dilated cardiomyopathy, 289 Digoxin Cholestasis dosage in relation to kidney function, 247 during heparin therapy, 471 Dilated cardiomyopathy Cholestatic jaundice and Chlamydia trachomatis infection, 289 cholesterol and phospholipid levels in, 17 Diurnal rhythm Cholesterol in antidiuretic hormone levels, 131 effect of cholestyramine on output rate, 241 Double paraproteins hypofibrinolysis and hypertension, 309 in Waldenstré6m’s macroglobulinaemia, 93 levels in post-infarction patients, 483 Drug development Cholestyramine diversity in receptor signalling, 391 effect on biliary lipid secretion, 241 Drug therapy Chromogranins and femoral neck fracture, 29 in pheochromocytoma patients, 453 antihypertensive, resistance to, 421 Chronic heart failure for thyrotoxicosis, 435 calcium and phosphofructokinase activity during Dysbetalipoproteinaemia Citation frequency clearance of remnant lipoproteins in, 97 and journal impact, 109 Coagulation Echocardiography effect of fish diet vs. meat diet, 317 and left atrial enlargement, 253 Coffee left ventricular function and wall thickness, 527 haemodynamic effects of, 501 Elastase antibodies Cognitive function autoimmune responses in glomerulonephritis, 261 effect of intensified insulin treatment, 9 Electrocardiography Collagenous colitis and exercise testing, 325 and prednisolone treatment, 443 Epidemiology Congestive heart failure of thyrotoxicosis, 415 antioxidant therapy in, 205 Erythrocyte sedimentation rate Coronary angiography and survival in lung cancer patients, 337 and exercise testing, 325 Erythropoietin Coronary artery disease levels in the anaemia of chronic disorders, 49 prediction by exercise testing, 325 effect of haematological parameters, 125 and lipid levels, 483 deficiency in crescentic glomerulonephritis, 363 Counterregulatory hormones Etodolac glycaemic thresholds for release of, 343 effects on the gastrointestinal mucosa, 5 Creatinine Exercise clearance in relation to digoxin dosage, 247 and third-degree atrioventricular block, 375 Crescentic glomerulonephritis Exercise testing erythropoietin deiiciency in, 363 degree of coronary artery disease predicted by, 325 Cryoglobulin in Waldenstr6m’s macroglobulinaemia, 93 Familial amyloidosis assessment of hypothalamic pituitary function in, 55 D-penicillamine Familial hypercholesterolaemia treatment for Wilson’s disease, 549 HMG CoA reductase inhibitors and gemfibrozil, 427 Depression Familial hypobetalipoproteinaemia and central hypothyroidism, 285 complicated by cerebellar ataxia and steatocystoma multiplex, Diabetes mellitus 197 dysbetalipoproteinaemia in, 97 Family studies effects of lisinopril and nifedipine in, 163 of hypobetalipoproteinaemia, 41 and carotid intima-media thickness, 225 Fatty acids treatment with felodipine, 233 and platelet function, 79 mild fasting hypertriglyceridaemia in, 267 and hypertriglyceridaemia in diabetes, 267 SUBJECT INDEX 569 Felodipine Hepatic lipase in treatment of hypertensive type II diabetics, 233 effect of ACTH 1-24, 201 effects on haemorheology in hypertension, 533 HMG CoA reductase inhibitors Femoral neck fracture to treat familial hypercholesterolaemia, 427 drug use and, 29 Hodgkin's disease Ferritin and osteomyelitis of the wrist, 467 effect of recombinant human erythropoietin on, 125 Hydralazine Fibrinolysis autoimmune responses in glomerulonephritis due to, 261 effect of fish diet vs. meat diet, 317 Hydrochlorothiazide Fibrosing adveolitis comparison with felodipine ER in hypertension, 533 induction by sulphasalazine, 553 Hypersensitivity pneumonitis Fish diet induction by sulphasalazine, 553 effect on blood lipids, coagulation and fibrinolysis, 317 Hypertension and ischaemic heart disease, 511] metformin treatment of insulin resistance in, 181 body weight and sodium content, 217 G-proteins hypofibrinolysis in patients with, 309 and receptor signalling, 391 resistance to drug therapy, 421 Gamma-glutamyl transferase effects of felodipine ER in, 533 positive predictive value for alcohol abuse, 497 Hyperthyroidism Gastric mucosal lesions thyroid-related hormones and goitre, 407 effects of etodolac and naproxen on, 5 Hypertriglyceridaemia Gemfibrozil in non-insulin-dependent diabetes, 267 to treat familial hypercholesterolaemia, 427 Hypervagotonia Glomerulonephritis and exercise, 375 autoimmune responses in, 261 Hypobetalipoproteinaemia Glucose tolerance not due to a mutation in the apo B gene, 41 effect of felodipine in diabetics, 233 Hypofibrinolysis Glycaemic thresholds hypertension and cholesterol levels, 309 for impairment of cognitive function, 343 Hypogammaglobulinaemia Glycoproteins subcutaneous IgG substitution, 73 breast cancer and adenocarcinoma, 463 Hypoglycaemia Goitre during intensified insulin treatment, 9 effects of cigarette smoking on, 67 counterregulatory hormonal response to, 293 variation in assessment of, 159 and impairment of cognitive function, 343 thyroid-related hormones and, 407 Hypothalamic-pituitary regulation and iodine intake, 415 in familial amyloidotic polyneuropathy, 55 Granulocytopenia Hypothyroidism gastric lymphoma causing, 193 due to isolated TRH deficiency, 285 Graves’ disease thyroid-related hormones and goitre, 407 and iodine intake, 415 and thyrotoxicosis, 435 Graves’ thyrotoxicosis incidence of recurrence and hypothyroidism, 435 Ibuprofen Growth hormone severe thrombocytopenia caused by, 281 regulation in familial amyloidotic polyneuropathy, 55 Infection serum erythropoietin levels during, 49 Haemodialysis Inflammation atrial natriuretic peptide during, 209 serum erythropoietin levels during, 49 haemodynamic effects Insulin of coffee and caffeine, 501 role in dysbetalipoproteinaemia, 97 Haemoglobin counterregulatory hormonal response to hypoglycaemia, effect of human erythropoietin on, 125 293 Haemolytic anaemia Insulin resistance and long-term ibuprofen use, 281 metformin treatment in hypertension, 181 Haemorheology and hypertriglyceridaemia in diabetes, 267 impairment after stroke, 457 Insulin treatment effects of felodipine ER in hypertension, 533 hypoglycaemic episodes during, 9 HDL cholesterol Interferon-alpha levels in viral hepatitis and cholestatic jaundice, 17 treatment in AIDS-associated Kaposi’s sarcoma, 35, 539 Heart rate Interleukin-6 effect of recombinant human erythropoietin on, 125 and AIDS-associated Kaposi's sarcoma, 539 Heparin therapy Iodine cholestasis during, 471 intake, toxic goitre and Graves’ disease, 415 Heparin-precipitable protein Ion channels in gastric lymphoma causing granulocytopenia, 193 and receptor signalling, 391 570 SUBJECT INDEX Iradipine Neurological diseases in severe chronic obstructive pulmonary disease mechanical ventilation in, 117 Ischaemic heart disease Neuropeptide Y and fish consumption, 511 in pheochromocytoma patients, 453 Islet cell antibodies Nifedipine in Sjégren’s syndrome, 61 effect on albuminuria and tubular transport functions, 163 Non-Hodgkin's lymphoma Journal impact and adrenocortical insufficiency, 377 and citation frequency, 109 NP59 scan localization of a unilateral aldosteronoma, 545 Kaposi’s sarcoma AIDS-associated, treatment of, 35 Obesity treatment with interferon-alpha, 539 and hypertriglyceridaemia in diabetes, 267 Ketotifen television viewing and life style, 301 efficacy in systemic mastocytosis, 475 and antihypertensive drug therapy, 421 Kidney function Observer variation digoxin dosage in relation to, 247 in clinical assessment of thyroid gland, 159 Obstructive lung disease Left ventricular function effect of isradipine on, 447 in diabetes mellitus, 527 Osteomalacia Leucocytes induced by antacid, 275 effect of recombinant human erythropoietin, 125 Osteomyelitis Lipoproteins and Hodgkin's disease, 467 and carotid intima-media thickness, 225 Lisinopril Pain effect on albuminuria and tubular transport functions, 163 and antihypertensive drug therapy, 421 Liver function tests Palpation and heparin therapy, 471 in assessment of thyroid gland, 159 Low density lipoprotein Pancreatic function effect of ACTH 1-24 on, 201 exocrine, in Sjogren's syndrome, 61 in familial hypercholesterolaemia, 427 Paraneoplastic syndrome Low-pressure receptors high cardiac output as a, 89 neuronal and humoral responses to stimulation of, 151 Pheochromocytoma Lung neoplasms associated with meningioma, 371 blood screening and survival, 337 chromogranins, neuropeptide Y and catecholamines in, 453 Lymphoma Phosphofructokinase high cardiac output in, 89 levels in chronic heart failure, 171 Phospholipids Malignant lymphoma levels in viral hepatitis and cholestatic jaundice, 17 causing granulocytopenia and cold intolerance, 193 effect of cholestyramine on output rates, 241 Meat diet Physical disability effect on blood lipids, coagulation and fibrinolysis, 317 and recent drug use, 29 Mechanical ventilation Plasma lipids in medical and neurological diseases, 117 and platelet function, 79 Medical diseases Plasma renin mechanical ventilation in, 117 activity during haemodialysis, 209 Meningioma Plasminogen activator inhibitor cvheochromocytoma associated with, 371 hypertension and cholesterol levels, 309 Monoclonal antibodies Platelet activity breast cancer and adenocarcinoma, 463 relationship to age and dietary habits, 79 Myeloperoxidase antibodies and long-term diet modification, 511 autoimmune responses in glomerulonephritis, 261 Pneumothorax Myocardial infarction in Wegener's granulomatosis, 189 prostacyclin production in, 135 Prednisolone rapid and correct diagnosis of, 143 to treat collagenous colitis, 443 reduction of analgesic requirement in, 257 Prehospital care Myocarditis and cause of death, 331 and Chlamydia trachomatis infection, 289 Primary aldosteronism bilateral adrenal tumours in, 545 Naproxen Prognosis effects on the gastrointestinal mucosa, 5 and mechanical ventilation, 117 Neoplasia Prolactin serum erythropoietin levels during, 49 regulation in familial and amyloidotic polyneuropathy, 55 Nephropathy Prostacyclin effects of lisinopril and nifedipine in diabetics with, 163 production in myocardial infarction, 135

See more

The list of books you might like

Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.